We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 278 results
  1. Implications of Tumor Immune Microenvironment and Molecular Markers for Cancer Immunotherapy

    The tumor immune microenvironment (TIME) of solid tumors consists of heterogeneous cell types, including immune cells (T cells, B cells, plasma...
    Luisa Maren Solis Soto, Huamin Wang in Handbook of Cancer and Immunology
    Living reference work entry 2022
  2. Overexpressed p-S6 associates with lymph node metastasis and predicts poor prognosis in non-small cell lung cancer

    Background

    Ribosomal protein S6 (S6), a downstream effect media of the AKT/mTOR pathway, not only is a part of 40S small subunit of eukaryotic...

    Yaoxiang Tang, Jiadi Luo, ... Qiuyuan Wen in BMC Cancer
    Article Open access 20 May 2022
  3. Extracellular Vesicles as Biomarkers for Cancer

    Because of the minimally invasive nature of biofluid collection, extracellular vesicles (EVs) have promising applications in the diagnosis,...
    Shuhong Wang, Yusheng Lin, ... Hao Zhang in Extracellular Vesicles
    Chapter 2024
  4. Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis

    Cholangiocarcinoma (CC) is the second most common tumor of the liver, originating from the biliary system with increasing incidence and mortality...

    Gábor Lendvai, Tímea Szekerczés, ... Katalin Borka in Pathology & Oncology Research
    Article 17 November 2018
  5. Research advances and treatment perspectives of pancreatic adenosquamous carcinoma

    Background

    As a malignant tumor, pancreatic cancer has an extremely low overall 5-year survival rate. Pancreatic adenosquamous carcinoma (PASC), a...

    Wen Zhang, **g Zhang, ... ** Ding in Cellular Oncology
    Article 01 November 2022
  6. Multidimensional fragmentomic profiling of cell-free DNA released from patient-derived organoids

    Background

    Fragmentomics, the investigation of fragmentation patterns of cell-free DNA (cfDNA), has emerged as a promising strategy for the early...

    Jaeryuk Kim, Seung-Pyo Hong, ... Jong-Il Kim in Human Genomics
    Article Open access 28 October 2023
  7. Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas

    Background

    CA19–9 is one of the most widely used tumor markers in biliary-pancreatic diseases. The measured value may not factually reflect the...

    Bangbo Zhao, Qin Cheng, ... Weibin Wang in BMC Cancer
    Article Open access 07 May 2021
  8. How much do we know about the metastatic process?

    Cancer cells can leave their primary sites and travel through the circulation to distant sites, where they lodge as disseminated cancer cells (DCCs),...

    Carolina Rodriguez-Tirado, Maria Soledad Sosa in Clinical & Experimental Metastasis
    Article Open access 23 March 2024
  9. Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer

    Background

    Pancreatic cancer is one of the most lethal tumors. The aim of this study is to provide an effective therapeutic discovery platform for...

    Sadanori Watanabe, Akitada Yogo, ... Etsuro Hatano in BMC Cancer
    Article Open access 03 May 2022
  10. Prognostic influence of endoscopic ultrasound-guided fine needle aspiration in IPMN-derived invasive adenocarcinoma

    Background

    Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for mucinous cystic neoplasm of the pancreas carries a potential risk of...

    Rei Suzuki, Hiroki Irie, ... Hiromasa Ohira in BMC Cancer
    Article Open access 12 October 2018
  11. Role of Circulating MicroRNAs in Prognosis and Diagnosis of Cancers

    Cancer causes a spectrum of diseases based on the nature of the human disease. The early detection of cancer is still a clinical challenge, despite...
    DKV Prasad, Vurla Prabhavathi, ... Imran Ali Khan in Role of MicroRNAs in Cancers
    Chapter 2022
  12. Circulating tumour DNA: a challenging innovation to develop “precision onco-surgery” in pancreatic adenocarcinoma

    Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the third leading cause of cancer-related mortality within the next decade. Management...

    Daniel Pietrasz, Elisabetta Sereni, ... Claudio Bassi in British Journal of Cancer
    Article 23 February 2022
  13. Familial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report

    Background

    Family history is one of the risk factors for pancreatic cancer. It is suggested that patients with pancreatic cancer who have a familial...

    Kodai Abe, Arisa Ueki, ... Akira Hirasawa in Hereditary Cancer in Clinical Practice
    Article Open access 07 January 2021
  14. Pancreatic cancer pathology viewed in the light of evolution

    One way to understand ductal adenocarcinoma of the pancreas (pancreatic cancer) is to view it as unimaginably large numbers of evolving living...

    Michaël Noë, Seung-Mo Hong, ... Ralph H. Hruban in Cancer and Metastasis Reviews
    Article Open access 08 February 2021
  15. Benign Disorders of the Breast in Pregnancy and Lactation

    Benign cystic or solid lumps frequently occur in the breasts of young women, and consequently can also be seen during pregnancy Pregnancies and...
    Nur Aishah Taib, Kartini Rahmat in Diseases of the Breast during Pregnancy and Lactation
    Chapter 2020
  16. Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer

    Pancreatic ductal metaplasia (PDM) is the transformation of potentially various types of cells in the pancreas into ductal or ductal-like cells,...

    ** **e in Cellular Oncology
    Article 15 March 2022
  17. Effects of intensive physiotherapy on Quality of Life (QoL) after pancreatic cancer resection: a randomized controlled trial

    Background

    Patients have significantly lower QoL scores after pancreatic resection due to cancer in the physical and psychological domains compared to...

    Dirk Weyhe, Dennis Obonyo, ... Navid Tabriz in BMC Cancer
    Article Open access 09 May 2022
  18. Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer

    Pancreatic cancer is one of the main causes of tumor-related deaths worldwide because of its low morbidity but extremely high mortality, and is...

    Yizhi Wang, Li Zhou, ... Gary Guishan **ao in Cancer Cell International
    Article Open access 15 September 2020
  19. Sortilin-induced lipid accumulation and atherogenesis are suppressed by HNF1b SUMOylation promoted by flavone of Polygonatum odoratum

    This study aims to investigate the impact of hepatocyte nuclear factor 1β (HNF1b) on macrophage sortilin-mediated lipid metabolism and aortic...

    Fang Liu, Shirui Chen, ... Yuncheng Lv in Journal of Zhejiang University-SCIENCE B
    Article 17 May 2023
  20. Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance

    In high-risk individuals participating in a pancreatic cancer surveillance program, worrisome features warrant for intensified surveillance or,...

    Kasper A. Overbeek, Djuna L. Cahen, ... M. A. Kuenen in Familial Cancer
    Article Open access 19 March 2020
Did you find what you were looking for? Share feedback.